A Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 10-1074

NCT02511990 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Healthy
HIV

Interventions

BIOLOGICAL: 3 mg/kg, single dose IV administration of 10-1074
BIOLOGICAL: 10 mg/kg, single dose IV administration of 10-1074
BIOLOGICAL: 30 mg/kg, single dose IV administration of 10-1074

Sponsor

Rockefeller University

Collaborators

[object Object]